Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Topical dutasteride shows promise for hair loss but needs more research.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Minoxidil sulfate, delivered through iontophoresis, can be used to treat hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Customizing non-invasive treatments for head and neck neuralgia improves patient outcomes.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

PRP treatment can safely improve short-term vision in acute NAION patients.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Both steroids effectively promote hair growth for at least 9 months.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Most patients improved with oral contraceptives, but some needed additional treatment.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.